Biogen on Wednesday warned that this year's profit could be as much as 10 percent below last year's.
Vertex Pharmaceuticals reported a first-quarter loss Wednesday of $22.1 million, or 29 cents a share, worse than analysts expected and wider than last year's first-quarter loss of $11 million, or 15 cents a share.
Affymetrix reported a first-quarter loss of $3.6 million, or 6 cents a share, compared with the year-ago loss of $10.8 million, or 19 cents a share. Excluding one-time items, the company reported earnings of $400, 000 or 1 cent a share for the latest quarter, while analysts expected a loss of 2 cents a share.
Abgenix said Tuesday its first-quarter net loss widened to $56.5 million, or 65 cents per share, from a net loss of $7.6 million, or 9 cents per share, in the 2001 first quarter